BE801588A - Nouveaux sels d'alpha-sulfobenzylpenicilline - Google Patents

Nouveaux sels d'alpha-sulfobenzylpenicilline

Info

Publication number
BE801588A
BE801588A BE132836A BE132836A BE801588A BE 801588 A BE801588 A BE 801588A BE 132836 A BE132836 A BE 132836A BE 132836 A BE132836 A BE 132836A BE 801588 A BE801588 A BE 801588A
Authority
BE
Belgium
Prior art keywords
sulfobenzylpenicillin
alpha
new salts
salts
new
Prior art date
Application number
BE132836A
Other languages
English (en)
French (fr)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of BE801588A publication Critical patent/BE801588A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE132836A 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline BE801588A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (xx) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
BE801588A true BE801588A (fr) 1973-12-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
BE132836A BE801588A (fr) 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline

Country Status (15)

Country Link
US (1) US3925357A (xx)
JP (1) JPS5512435B2 (xx)
AT (1) AT325206B (xx)
AU (1) AU469986B2 (xx)
BE (1) BE801588A (xx)
CA (1) CA996548A (xx)
CH (1) CH573435A5 (xx)
CS (1) CS168036B2 (xx)
DE (1) DE2332840A1 (xx)
FR (1) FR2190414B1 (xx)
GB (1) GB1386566A (xx)
HU (1) HU166029B (xx)
NL (1) NL7308048A (xx)
PL (1) PL92969B1 (xx)
SE (1) SE402916B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (xx) * 1978-07-29 1980-02-13
SK288003B6 (sk) * 2001-02-24 2012-10-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthin derivatives, method for the preparation thereof, pharmaceutical composition containing thereof and their use
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CN109503584A (zh) 2006-05-04 2019-03-22 勃林格殷格翰国际有限公司 多晶型
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
WO2009024542A2 (en) * 2007-08-17 2009-02-26 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0917675A2 (pt) * 2008-08-15 2015-12-01 Boehringer Ingelheim Int compostos orgânicos para cura de ferida
MX2011002558A (es) 2008-09-10 2011-04-26 Boehringer Ingelheim Int Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru) 2008-12-23 2015-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Солевые формы органического соединения
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
EP2566469B1 (en) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Combination therapy
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en) 2011-07-15 2014-11-11 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (xx) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
PL92969B1 (xx) 1977-04-30
SE402916B (sv) 1978-07-24
HU166029B (xx) 1974-12-28
CS168036B2 (xx) 1976-05-28
FR2190414A1 (xx) 1974-02-01
CH573435A5 (xx) 1976-03-15
JPS5512435B2 (xx) 1980-04-02
CA996548A (en) 1976-09-07
AU5760073A (en) 1975-01-09
JPS4925121A (xx) 1974-03-06
FR2190414B1 (xx) 1976-07-02
GB1386566A (en) 1975-03-12
DE2332840A1 (de) 1974-01-17
US3925357A (en) 1975-12-09
AU469986B2 (en) 1976-02-26
NL7308048A (xx) 1974-01-03
AT325206B (de) 1975-10-10

Similar Documents

Publication Publication Date Title
BE801588A (fr) Nouveaux sels d'alpha-sulfobenzylpenicilline
IT995086B (it) Monoacetali di 1 2 dichetoni aromatici
BE803001A (fr) Generateur d'ultra-sons
BE793601A (fr) Generateur d'ultrasons
BE748699A (fr) Nouveaux sels d'ammonium quaternaire polyfluores
BE799586A (fr) Sels de l'acide 3-hydroxyi2-hydroxymethylpropane-sulfonique-1
BE796359A (fr) Composition d'oeuf synthetique
BE798485A (fr) Production d'esters
BE796216A (fr) Nouveaux sels de metaux d'acides dithiocarbamiques
IT1045864B (it) Accouplement d'ambre
IT1004018B (it) Preparazione di poliammidi
IT987593B (it) Solfoni con concatenazione di dineti o 1 6 esadien 1 5 ilene
BE808899A (fr) Nouveaux acides et sels cyanophenylene-dioxamiques
BE788335A (fr) Nouveaux sels d'ammonium quaternaires polyfluores
BE802272A (fr) Nouveaux sels de vincanol
BR7306933D0 (pt) Tesourao
BE780630A (fr) Nouveaux derives d'imidazo-pyridine
BE770581A (fr) Nouveaux sels de cephalexine
BE798531A (fr) Derives o-substitues d'oximes
BE795474A (fr) Sels alcalins d'acides polyester-carboxyliques, et leur preparation
FR2324632A1 (fr) Nicotinamide-n-ethyl-thionicotinate et ses sels
AR197318A1 (es) Nuevos colorantes antraquinonicos de dificil solubilidad en agua
BE796447A (fr) Nouveaux esterimides d'acides n-(aminomethylidene)-thiol-phosphoriques
BE795041A (fr) Nouveaux derives de l'amino-propane
BE808147A (fr) Nouveaux derives de 2'-fluorobiphenyles